04.25.2014

Romanian state-run drug-maker Antibiotice Iasi (ATB.RO) is paying dividends totaling RON15.4 million, nearly half of the profit it made in 2013, and the Health Ministry, the majority shareholder, gets more

03.26.2014

Zentiva Bucuresti (SCD.RO) is paying the highest dividend of all pharmaceutical producers listed on the Bucharest stock market, while Biofarm (BIO.RO) will not be paying any. Analysts’ favorite, more

03.21.2014

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) proposes a dividend payment of 15.4 million lei (EUR3.44 million) from the 2013 profits, the company said in a call to its shareholders. more

02.21.2014

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) estimates its profit will grow by 6% on the year in 2014, to 30.55 million lei (EUR6.7 million), while the company's investments will reach more

02.11.2014

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Tuesday reported a preliminary net profit of 28.8 million lei (EUR6.4 million), up 6.3% on the year, mainly due to a higher operating profit. more

01.15.2014

Romanian state-run drug maker Antibiotice Iasi (ATB.RO) is likely to register two-digit export growth this year as it eyes new markets. more

12.29.2013

Health Ministry-owned drug producer Antibiotice Iasi (ATB.RO) estimates this year's exports to amount to more than $26 million or 30% of its total sales. more

11.14.2013

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Thursday reported a 37.4% drop in its nine-month profit to 16.7 million lei (EUR3.8 million), from RON26.7 million a year earlier. more

10.03.2013

The shares of drug producers Antibiotice Iasi (ATB.RO) and Biofarm Bucuresti (BIO.RO) generated over 50% profits in the past year, including the dividends paid to shareholders, which makes them some more

09.23.2013

Romania’s state-run drugmaker Antibiotice Iasi can grow to become a player in the region, but with support from an investor and improved legislation, the company’s general manager Ioan Nani said more

08.14.2013

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Wednesday said its net profit fell 37.3% to 16.1 million lei (EUR3.63 million) in the first half of 2013, on lower sales. more

08.07.2013

Romanian state-run drug maker Antibiotice Iasi (ATB.RO) is looking to open offices in ten countries, including Poland, Czech Republic, Slovakia, Ukraine, and Serbia, to increase its visibility and more

08.06.2013

Sales of Romanian state-run drug maker Antibiotice Iasi (ATB.RO) declined 4% in the first half of the year, to RON141.8 million (EUR32.3 million), and its net profit dropped 37%, to RON16.1 million more

07.02.2013

Romanian state-run drug maker Antibiotice Iasi (ATB.RO) has borrowed 60 million lei (EUR13.5 million) from lender EximBank to finance its activity. more

06.27.2013

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will increase its share capital by 10.3 million lei (EUR2.3 million) to RON67.1 million, according to a shareholder decision Thursday. more

05.15.2013

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Wednesday said its net profit fell 57.6% to 5.5 million lei (EUR6 million) in the first three months of 2013, as domestic sales were hit by weak more

04.04.2013

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) estimates its net profit will rise 6% to 29 million lei (EUR6.5 million) in 2013, according to the company’s revenue and expenditure budget for more

02.20.2013

Romanian state-owned drugmaker Antibiotice Iasi SA (ATB.RO) Wednesday said its preliminary net profit rose 33% in 2012 to 27.4 million lei (EUR6.1 million). more

01.29.2013

Romanian state-run drug producer Antibiotice Iasi (ATB.RO) forecasts 17% higher exports in 2013 from $20 million in 2012, fueled by expanded partnerships on the US market as well as on other more

12.26.2012

Romanian state-run drug producer Antibiotice Iasi (ATB.RO) is aiming for EUR124 million sales by 2016, an increase of 77% from the almost EUR70 million expected this year. more

12.20.2012

Romanian state-owned drug producer Antibiotice Iasi (ATB.RO) will hit its sales and profit targets this year, says general manager Ioan Nani, while 2013’s sales should follow the trend of the more

11.15.2012

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Thursday said its net profit rose 7% to 26.6 million lei (EUR6 million) in the first nine months, fueled by a similar increase in sales. more

10.17.2012

The Romanian Government Wednesday authorized the purchasing of 27 vehicles for Romanian state-owned drugmaker Antibiotice Iasi SA (ATB.RO), which is aimed to increase the number of sales agents as more

08.09.2012

Romanian state-owned drugmaker Antibiotice Iasi SA (ATB.RO) Thursday said its net profit rose 11.2% on the year to 25.75 million lei (EUR5.8 million) in the first half, helped by higher sales. more

06.21.2012

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) took two credit lines of EUR9.5 million and 8 million lei (EUR1.8 million) to finance its working capital, the company said in a statement sent more